微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 0.98% | 180% | 75% | 91/133 | 0.43% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 0.56% | 522.22% | 700% | 90/133 | 1.89% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.07% | -86% | 103.43% | 102/133 | 1.06% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -2.04% | -205.15% | -682.86% | 101/133 | 3.16% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 0.35% | -91.38% | 288.89% | 106/133 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 0.09% | -95.67% | -82% | 98/133 | 3.08% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 0.5% | -66.22% | -74.23% | 88/133 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 1.94% | -68.71% | -52.22% | 95/133 | 5.16% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 4.06% | -20.39% | 95.19% | 72/133 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 2.08% | -6.73% | 40.54% | 84/133 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.48% | 40.95% | -76.13% | 74/133 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 6.2% | -55.3% | 21.57% | 89/133 | 13.33% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 5.1% | -59.2% | 128.7% | 84/133 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 2.23% | -60.6% | 112.38% | 92/133 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.05% | -43.85% | -92.43% | 85/133 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 13.87% | -2.73% | 10.96% | 62/133 | 17.4% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 12.5% | 2% | 120.85% | 47/133 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 5.66% | 332.06% | 202.67% | 75/133 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.87% | 2% | -86.89% | 78/133 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 14.26% | 25.53% | 988.55% | 67/133 | 25.69% | 中红医疗 | 168% | 行业排名> |
| 2020-06-30 | 1.31% | 2% | -88.47% | 98/133 | 15.16% | 圣湘生物 | 112.46% | 行业排名> |
| 2019-12-31 | 11.36% | -0.87% | -0.87% | 71/133 | 14.38% | 博拓生物 | 108.13% | 行业排名> |
| 2018-12-31 | 11.46% | -17.97% | -17.97% | 63/133 | 12.98% | 圣湘生物 | 29.33% | 行业排名> |
| 2017-12-31 | 13.97% | 2% | 2% | 48/133 | 13.82% | 健尔康 | 84.09% | 行业排名> |